Tansin Tablets 1mg "EVEREST"

"永勝" 糖欣錠 1毫克
Tansin Tablets 1mg "EVEREST"


Repaglinide ……1mg

Package 15's x 60PTP/ Box


Signa (Sig.)

Repaglinide should be taken before meals and adjusted as needed to achieve optimal glycemic control. Patients should self-monitor blood glucose and/or urinary blood glucose. The physician should also periodically check the patient's blood glucose to determine the patient's minimum effective dose. Glycated hemoglobin values can also be used to monitor the patient's therapeutic effect. Regular monitoring is necessary to detect an insufficient hypoglycemic effect (primary failure) when using the maximum recommended dose and to lose sufficient hypoglycemic effect (continuous failure) after the initial efficacy phase. In Type 2 diabetes, which achieves good results through diet control, short-term use of repaglinide should be sufficient during temporary loss of glycemic control.

Children's group

The safety and efficacy of repaglinide in children under 18 years of age has not been established. Currently unfunded


Method of administration

Please take it orally within 15 minutes of the meal, but also before or just 30 minutes before the meal (ie 2, 3 or 4 times a day with meals). If the patient is taking one less meal (or more than one meal), he or she should take less (or take more) with the meal as directed by the physician.

When used in combination with other drugs, please refer to the special warnings and precautions in use and interactions with other drugs and other forms of interaction.

Initial dose

It should be determined by the physician based on the patient's blood glucose response. If the patient has not used hypoglycemic drugs, it is recommended to start with 0.5 mg per meal and adjust the dose according to the glycemic response every week or every two weeks. If the patient has previously used other oral hypoglycemic agents, it is recommended to start with 1 mg per meal.

Maintenance dose

The maximum recommended dose for a single dose is 4 mg per meal and the maximum daily dose should not exceed 16 mg.

Patients who previously used other oral hypoglycaemic agents (OHAs) can be directly converted to repaglinide by other hypoglycemic agents. However, there is no direct relationship between the dose of repaglinide and other oral hypoglycemic drugs. The maximum initial dose for patients to start switching to repaglinide is recommended to take 1 mg before meals.

Oral hypoglycemic drugs

Treatment with repaglinide, metformin or thiazolidinediones alone is not effective

When controlling blood sugar, you can use repaglinide with metformin or thiazolidinediones.

The initial dose of Repaglinide is the same as when used alone. The dose of each oral hypoglycemic agent should be adjusted according to the patient's blood glucose response.

Storage Refer Leaflet
Health Insurance Code AC48660100
DOH Manufacturing No. DOH. Ref. No 048660

Related Products